购物车
- 全部删除
- 您的购物车当前为空
Rezvilutamide (SHR3680)是一种可口服且可穿过血脑屏障的雄激素受体 (androgen receptor) 抑制剂,具有抗肿瘤活性。Rezvilutamide (SHR3680) 可用于研究转移性去势抵抗性前列腺癌。
Rezvilutamide (SHR3680)是一种可口服且可穿过血脑屏障的雄激素受体 (androgen receptor) 抑制剂,具有抗肿瘤活性。Rezvilutamide (SHR3680) 可用于研究转移性去势抵抗性前列腺癌。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 743 | 5日内发货 | |
5 mg | ¥ 1,830 | 现货 |
产品描述 | Rezvilutamide (SHR3680) is an orally available androgen receptor inhibitor that crosses the blood-brain barrier and has antitumor activity.Rezvilutamide (SHR3680) is used in the study of metastatic desmoplasia-resistant prostate cancer. |
别名 | 瑞维鲁胺, SHR3680 |
分子量 | 479.47 |
分子式 | C22H20F3N3O4S |
CAS No. | 1572045-62-5 |
Smiles | CC1(C)N(C(=S)N(C1=O)c1ccc(C#N)c(c1)C(F)(F)F)c1ccc(OC[C@@H](O)CO)cc1 |
密度 | 1.50 g/cm3 (Predicted) |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 80 mg/mL (166.85 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容